Surging Covid-19 cases urge use of booster shot vaccines in Europe
  Author: Pankaj Singh

Soaring coronavirus cases have broken past records in Europe, once again putting the continent at the epicenter of the pandemic. As a result of unprecedented events, health experts ...

Read More >>
Apollomics enrolls first patient in Phase 3 trial of leukemia drug
  Author: Mateen Dalal

GlycoMimetics, Inc., a firm that develops molecule drugs, has recently announced that biotech company Apollomics has dosed first patient in China in a Phase 3 clinical trial of its new relapsed or refractory acute myel...

Read More >>
Ascletis-Suzhou enter worldwide license agreement for Envafolimab
  Author: Mateen Dalal

Chinese biotechnology company, Ascletis Pharma Inc. has entered into a worldwide license agreement with Suzhou Alphamab Co., Ltd., outside Greater China for ASC22 (Envafolimab) for the treatment of all viral diseases i...

Read More >>
LightForce bags $50Mn to offer new 3D Printed Orthodontics solutions
  Author: Vikas M

Renowned orthodontic solutions provider, LightForce Orthodontics has reportedly secured $50 million in a Series C financing round led by Kleiner Perkins along with participates including Tyche Partners, AM Ventures and...

Read More >>
Antengene receives IND approval for Phase 1 Trial of ATG-101
  Author: Mateen Dalal

Antengene Corporation Limited, a leading biopharmaceutical company, has successfully received approval from the US FDA (Food and Drug Administration) for Investigational New Drug (IND) application of ATG-101, a potenti...

Read More >>
FINVASIA plans to expand in healthcare with Gini Health acquisition
  Author: Vikas M

FINVASIA, an Indian fintech company, has recently announced that it has acquired Gini Health, a personalized health & nutrition company based in Canada. The move is in line with FINVASIA’s plan to s...

Read More >>
Novartis lung cancer drug fails to meet endpoints in Phase III trial
  Author: Pankaj Singh

Renowned pharmaceutical company, Novartis has recently disclosed that its lung cancer drug ‘canakinumab’ has failed again in meeting its goal of improving overall survival rates in lung cancer patients and ...

Read More >>
Abbott unites with Real Madrid to aid child welfare worldwide
  Author: Mateen Dalal

Abbott’s partnership with Real Madrid will cater to children’s education, social welfare, sports activities in around 80 countries It ...

Read More >>
New Zealand prepares to deal with potential surge in COVID-19 cases
  Author: Mateen Dalal

New Zealand is preparing for an increase in Covid-19 cases after registering 94 new infections over the weekend, with pandemic modelers predicting that if the government continues on its present path, new cases would r...

Read More >>
Pfizer urges FDA to approve COVID-19 vaccine for kids aged 5 to 11
  Author: Vikas M

Pharma majors, Pfizer and BioNTech have recently requested the FDA to approve emergency use of their coronavirus vaccine for children aged between 5 to 11. If approved, the vaccine rollout could potentially protect mor...

Read More >>
Genomic Vision unveils TeloSizer® for precise cellular health analysis
  Author: Mateen Dalal

Genomic Vision, a molecular diagnostics and technology company that develops tools and services focused on examining and controlling changes in the genome, has recently announced the unveiling of TeloSizer®, an adv...

Read More >>
Innovent, AnHeart present interim data from Taletrectinib Phase 2 trial
  Author: Mateen Dalal

Innovent Biologics, Inc., a biopharmaceutical company, and AnHeart Therapeutics Co., Ltd. have jointly announced interim clinical data from a Phase 2 trial (TRUST) evaluating Taletrectinib (AB-106), an investigational ...

Read More >>
Health insurer Alan acquires Jour to enter the mental health market
  Author: Mateen Dalal

Alan, a health insurance startup based in France, has acquired American digital behavioral health firm, Jour for $20 million. The acquisition has assisted the French health insurer to launch its new digital health...

Read More >>
CVS Health plans to recruit 25,000 people ahead of flu season
  Author: Pankaj Singh

American healthcare company, CVS Health Corp. says that it will hire up to 25,000 people for clinical and retail job positions ahead of the flu season at a time when administration of booster COVID-19 vaccination jabs ...

Read More >>
Saudi Healthtech firm Clinicy banks huge funds in pre-Series A round
  Author: Mateen Dalal

Clinicy, an innovative healthtech firm based in Saudi Arabia, has roped in a seven-figure funding from Mad'a Investment Company, a private equity firm headquartered in Riyadh. While the specific amount of the inves...

Read More >>
MiSalud to launch digital health & wellness platform for Hispanics
  Author: Vikas M

The COVID-19 pandemic has drawn light to some key challenges faced by Hispanic communities in the U.S. to access healthcare services. Aiming to offer personalized health services to these communities, digital healthcar...

Read More >>
Pfizer submits clinical data to FDA for vaccine booster shot approval
  Author: Mateen Dalal

Leading vaccine developers, Pfizer and BioNTech have recently submitted primary stage clinical data to the U.S. FDA (Food and Drug Administration) as a part of their efforts to authorize booster vaccine shot for COVID-...

Read More >>
FDA approves 3rd COVID-19 vaccine jab for immunocompromised people
  Author: Mateen Dalal

The U.S. FDA (Food and Drug Administration) has revised the emergency use authorizations (EUA) status of the Pfizer and Moderna Covid-19 vaccines to permit people with weakened immune systems to receive its third dose....

Read More >>
Zydus Cadila seeks regulatory approval for its COVID vaccine, ZyCov-D
  Author: Vikas M

Zydus Cadila, an Indian pharmaceutical company, has reportedly approached the top drug regulator in the country to seek restricted emergency approval of its 3-dose COVID-19 vaccine, ZyCov-D. ...

Read More >>
Asceltis receives China IND nod for clinical trials of ASC42 for CHB
  Author: Pankaj Singh

Elevating cases of chronic hepatitis B (CHB) has now impelled Asceltis Pharma Inc., a data driven biotech firm in China, to experiment towards developing drugs that can, to some extent, reduce the impact of CHB in the ...

Read More >>
HighTide’s Type 2 Diabetes treatment gets clinical trial nod in China
  Author: Vikas M

HighTide Therapeutics, a clinical-stage biopharmaceutical entity that focuses on the development of new therapies for the treatment of gastrointestinal diseases, chronic liver illnesses, and metabolic disorders, has an...

Read More >>
EndoFresh’s Disposable Digestive Endoscopy System gets an FDA nod
  Author: Mateen Dalal

The US Food and Drug Administration has finally produced a green flag to EndoFresh’s novel Disposable Digestive Endoscopy System following years of reports of persistent cross-contamination issues transmitted in ...

Read More >>
InVita announces investment in STACS DNA to streamline sample tracking
  Author: Pankaj Singh

The U.S -based InVita Healthcare Technologies has recently announced investing an undisclosed amount in STACS DNA, a prominent leader in sexual assault kit tracking and software provider. ...

Read More >>
Amazon, Greenko expedite oxygen supplies to India amid critical shortage
  Author: Pankaj Singh

While India is currently facing the wrath of the second wave of corona-virus due to acute shortage of oxygen concentrators, various companies have forward to help the country get back on track. Amongst these are Hydera...

Read More >>
Gennova begins enrollment for Phase 1/2 trials of mRNA COVID vaccine
  Author: Mateen Dalal

India's first mRNA-based COVID-19 vaccine, HGCO19, formulated by Pune-based biotech firm, Gennova Biopharmaceuticals is about to enter its Phase 1/2 clinical trials with the enrollment of candidates, said the Department of Biotechnology (DBT)....

Read More >>
Adverum Biotechnologies announces new data from OPTIC Phase 1 trial
  Author: Pankaj Singh

Adverum Biotechnologies, a California based biotech company, has reportedly announced new clinical data from the OPTIC Phase 1 with dose ranging clinical stage trial of gene therapy intravitreal injection namely ADVM-022. The OPTIC trial h...

Read More >>
Aduro begins trial of MK-5890 for non-small cell lung cancer treatment
  Author: Mateen Dalal

The biopharmaceutical giant has also received a USD 10 million development milestone payment from Merck & CO. for the initiation of the trial A clinic...

Read More >>
Premier to buy two Greater New York Hospital Association subsidiaries
  Author: Pankaj Singh

Premier Inc., a renowned healthcare improvement company, has reportedly announced that it has entered a definitive agreement to purchase certain liabilities and all the assets of Nexera, Inc. and Acurity, Inc., two who...

Read More >>
TherapeuticsMD submits a New Drug Application to the FDA for BIJUVA®
  Author: Mateen Dalal

TherapeuticsMD, Inc., an inventive pharmaceutical company that focuses on women healthcare, has recently announced that it has presented a New Drug Application (NDA) pre-approval efficacy supplement to the U.S. FDA (Fo...

Read More >>
Cerevel Therapeutics begins CVL-936 trial for treating drug addiction
  Author: Mateen Dalal

Cerevel Therapeutics, LLC, a biopharmaceutical company developing new therapies for treating neuroscience diseases, has reportedly dosed healthy volunteers in Phase 1 clinical trial of CVL-936, a potential first-in-cla...

Read More >>
NextGen announces a new strategic collaboration with Doctible
  Author: Pankaj Singh

NextGen Healthcare, a renowned electronic health record software developer, reportedly announced its exclusive collaboration with Doctible, a platform that allows healthcare providers to gain real-time feedback from th...

Read More >>
Syros Pharma begins first in-human trial of oral CDK7 inhibitor
  Author: Mateen Dalal

Syros Pharmaceuticals, a leading biotechnology company focused upon developing medicines for controlling and altering expression of genes, recently announced that the first patient has been dosed in the clinical trial ...

Read More >>
Nabis Holdings contemplates joint venture with Panaxia Pharmaceutical
  Author: Mateen Dalal

Nabis Holdings Inc., is apparently thinking of inking a joint venture (JV) with the Israel company Panaxia Pharmaceutical Industries, Ltd. Reportedly, the MOU signed between the two companies mandates Panaxia to offer ...

Read More >>
NantHealth & NantOmics launch AI platform for subtyping Lung Cancer
  Author: Mateen Dalal

NantHealth, Inc., a personalized, evidence-based, next-generation healthcare company and NantOmics, LLC, one of the leading companies in molecular analysis, have reportedly launched an innovative AI platform for assist...

Read More >>
Genentech reveals submission of sBLA to FDA for Tecentriq-Avastin
  Author: Pankaj Singh

Genentech, Inc., a subsidiary of the Roche Group, has reportedly announced the completion of a sBLA (supplemental Biologics License Application) submission to the U.S. FDA (Food and Drug Administration) for Tecentriq &...

Read More >>
FDA issues a cybersecurity warning for GE medical equipment
  Author: Pankaj Singh

The U.S. Food and Drug Administration, an agency within the U.S. Department of Health and Human Services, recently issued a safety communication informing patients, health care providers and facilities regarding t...

Read More >>
French-Belgian biotech PDC*LINE bags USD 22.2M in a Series B funding
  Author: Pankaj Singh

A clinical stage biotechnology company, PDC*line Pharma, focused upon developing a new class of effective and scalable active immunotherapies for treating cancers, recently announced completion of a Series B ...

Read More >>
Verrica unveils positive data from VP-102 study in molluscum treatment
  Author: Mateen Dalal

Findings from the study are being produced at the 17th Annual Winter Clinical Dermatology Conference in Kohala Coast The data indicated ...

Read More >>
EQRx to offer new and innovative medicines at affordable prices
  Author: Mateen Dalal

Amidst all the recurring headlines of patients complaining about expensive medicines and treatments, EQRx, a novel biotechnology company, has comes up with plans to create novel, patent-protected drugs at affordable pr...

Read More >>
Oyster Point Pharma attains primary endpoint in MYSTIC trial
  Author: Pankaj Singh

A clinical-stage biopharmaceutical company, Oyster Point Pharma, Inc. recently announced positive results from its Phase 2 MYSTIC clinical study for Dry Eye Disease. For the record,...

Read More >>
Biotech firm Agenus to begin Phase 1 clinical trial with AGEN1223
  Author: Mateen Dalal

Agenus Inc., a U.S. based immuno-oncology firm, has announced that it has started dosing its first patient with AGEN1223, a novel bi-specific antibody developed to reduce regulatory T cells in the tumor microenvironmen...

Read More >>
DBV Technologies reports positive results of Viaskin Peanut study
  Author: Mateen Dalal

  The biopharmaceutical firm reported positive results from the PEOPLE Phase-3 study of Viaskin Peanut in the children suffering from the peanut allergy. ...

Read More >>
Novan declares top-Line efficacy results from Phase 3 trials of SB206
  Author: Mateen Dalal

B-SIMPLE2 trial was statistically considerable for numerous pre-specified sensitivity analyses. Similar assessments with B-SIMPLE1 showed reasonably supportive and consistence results of B-SIMPLE2....

Read More >>
Google’s AI system reportedly capable of detecting breast cancer
  Author: Mateen Dalal

Radiologists miss nearly 20% of breast cancer spotting in mammograms Google’s AI technology is developed with Alphabet Inc.’s DeepMind AI   As per a latest ...

Read More >>
Principia updates anticipated final result from PRN1008 trial
  Author: Pankaj Singh

Principia Biopharma Inc. recently updated about the anticipated timings for the final result from the ongoing trial of PRN1008 data in patients suffering from pemphigus, along with CRR (complete response rates) from it...

Read More >>
Digital Ally partners with Pivot to develop next-gen breathalyzer
  Author: Pankaj Singh

Digital Ally Inc., a manufacturer and marketer of innovative video recording products for emergency management, law enforcement, fleet safety, and security has reportedly announced its partnership with Pivot Internatio...

Read More >>
Stem Holdings inks agreement to acquire 100% of Seven Leaf Ventures
  Author: Pankaj Singh

The new definitive agreement would allow Stem to foray into the lucrative California dispensary market."   After successful comple...

Read More >>
U.S. FDA gives nod to first generic version of Eliquis tablets
  Author: Mateen Dalal

The U.S. FDA (Food and Drug Administration) has reportedly made headlines after it recently approved the first generic versions of Eliquis (apixaban) tablets in the U.S. The generic tablets are formulated to ...

Read More >>
BeiGene receives approval for REVLIMID® new drug application in China
  Author: Mateen Dalal

BeiGene, Ltd., a China based biopharmaceutical company, that focuses on developing and commercializing immuno-oncology and molecularly targeted drugs to treat cancer, has reportedly announced that the NMPA that is Nati...

Read More >>
Eleusis evaluates potential of LSD in treating Alzheimer’s Disease
  Author: Mateen Dalal

A clinal stage life science company, Eleusis recently announced results from the Phase 1 clinical trial of LSD (Lysergic Acid Diethylamide), demonstrating the potential of the orally administered low doses of the drug ...

Read More >>
FTC bars Illumina from acquiring DNA sequencing rival PacBio
  Author: Pankaj Singh

The Federal Trade Commission, commonly abbreviated as FTC has blocked the acquisition of Pacific Biosciences (PacBio) by its established rival Illumina. Illumina is a leading biotechnology company specializing in manuf...

Read More >>
Belantamab mafodotin shows positive ORR in a recent DREAMM-2 study
  Author: Mateen Dalal

GlaxoSmithKline, a UK-based pharmaceutical company recently announced treatment of patients with heavily pre-treated multiple myeloma with belantamab mafodotin, an investigational agent. The study resulted in a clinica...

Read More >>
Wave Life Sciences to discontinue development of suvodirsen for DMD
  Author: Pankaj Singh

The results from the clinical study rendered no change from baseline in dystrophin expression Clinical stage genetic medicines company- Wave Life Sciences Ltd. has ...

Read More >>
Roche announces new data from Phase 3 FeDeriCa trial for breast cancer
  Author: Pankaj Singh

Roche Holding, a renowned Swiss healthcare company working in pharmaceuticals and diagnostics, reportedly announced novel data from its Phase 3 FeDeriCa trial. The trial showed the investigational FDC (fixed-dose combi...

Read More >>
Biothera unveils updated data from Phase 2 mTNBC trial at SABCS
  Author: Mateen Dalal

Biothera Pharmaceuticals, Inc., a renowned Minnesota based biotechnology company, reportedly announced that clinical benefit data and updated response from its Phase 2 study in chemo-refractory mTNBC (metastatic triple...

Read More >>
argenx publishes positive results from efgartigimod Phase 2 ITP trial
  Author: Mateen Dalal

argenx, a renowned Netherlands based biotechnology firm, reportedly announced the publication of outcomes from the assessment of its FcRn antagonist, efgartigimod, in a Phase 2 ITP clinical trial, in the American Journ...

Read More >>
KCV inks composite assembly manufacturing deal with Carestream Health
  Author: Mateen Dalal

Kaman Composites Vermont, also known as KCV and a subsidiary of Kaman Corporation, a renowned aerospace company, reportedly announced a manufacturing contract with Carestream Health, an independent subsidiary of Onex C...

Read More >>
Genentech announces updated data from Venclexta® clinical trials
  Author: Pankaj Singh

Chronic lymphocytic leukemia (CLL) is a common type of adult leukemia. In the United States, it is estimated that more than 20,000 new cases of CLL will be diagnosed in 2019. With an eye to cure CLL, biotechnology comp...

Read More >>
CoSara receives Indian regulatory authorization for its five IVDs
  Author: Pankaj Singh

Co-Diagnostics, a renowned US-based molecular diagnostics company, having a patented, unique platform to develop diagnostics tests reportedly announced that CoSara Diagnostics, the company’s JV for production, ha...

Read More >>
NantKwest announces Phase 1 results of PD-L1.t-haNK cell therapy
  Author: Mateen Dalal

NantKwest Inc., a U.S.-based clinical-stage immunotherapy company, has reportedly announced encouraging safety data generated from the first six patients in its QUILT-3.064 clinical trial. The study is conducted t...

Read More >>
Chugai to sell C&C Research Laboratories stake to JW Pharmaceutical
  Author: Mateen Dalal

Japan’s research-based pharma company, Chugai Pharmaceutical Co., Ltd. has recently made it to headlines when it agreed to change the equity structure of C&C Research Laboratories (C&C), a Korea...

Read More >>
Clover Biopharmaceuticals closes $43 million Series B investment round
  Author: Mateen Dalal

Clover Biopharmaceuticals, a renowned research-based, clinical-stage biotechnology firm, reportedly announced that it has closed a $43 million Series B investment round. The investm...

Read More >>
Cinda finalizes Phase I study of anti-PD-1 / HER2 bispecific antibody
  Author: Pankaj Singh

Cinda Biopharmaceutical, a startup that focuses on treating autoimmune and metabolic diseases, has recently announced the completion of its Phase I clinical study of human epidermal growth factor receptor-2 (HER2) and ...

Read More >>
TFF Pharmaceuticals commences Phase 1 clinical trial for Voriconazole
  Author: Mateen Dalal

TFF Pharmaceuticals, Inc., claims that it has initiated Voriconazole Inhalation Powder’s phase 1 clinical trial —Voriconazole’s inhaled dry powder version that is direct-to-lung and complements next-g...

Read More >>
DNAtrix unveils positive Phase 2 DNX-2401 study results at SNO Meeting
  Author: Pankaj Singh

  The company’s drug candidate DNX-2401 in combination with Pembrolizumab depicted clinical benefit in brain tumors like Recurrent Glioblastoma.  ...

Read More >>
Harpoon Therapeutics & AbbVie sign HPN2017 license agreement
  Author: Mateen Dalal

Clinical-stage immunotherapy firm Harpoon Therapeutics & biopharma company AbbVie Inc have reportedly announced a collaboration to obtain a global license for HPN217. HPN217 is a BCMA (B cell maturation antigen) - ...

Read More >>
LabCorp and QIAGEN extend QCI license deal to strengthen relationship
  Author: Mateen Dalal

QIAGEN N.V., a leader in molecular diagnostics and pharmaceutical research, recently revealed a new agreement with North Carolina based LabCorp® to extend its Clinical Insights (QCI) license with its Human Gene Mut...

Read More >>
Caladrius unveils positive results of CLBS16 in CMD treatment
  Author: Pankaj Singh

The data shows a major statistical improvement in coronary flow reserve   Single-use CLBS16 can reportedly improve heart function and s...

Read More >>
BeiGene’s BRUKINSA wins accelerated approval from the FDA for MCL
  Author: Mateen Dalal

BRUKINSA is the first product from BeiGene to get approval from the FDA   84% of patients who are talking BRUKINSA have achieved an ORR...

Read More >>
Deciphera to present data from DCC-3014 trial at CTOS annual meet
  Author: Mateen Dalal

The ongoing clinical trial of DCC-3014 have shown preliminary anti-tumor activity.    DCC-3014 validates emerging tolerability profile...

Read More >>
Merck acquires Calporta Therapeutics from COI Pharmaceuticals
  Author: Pankaj Singh

Merck will pay up to $576 million for the acquisition   Preclinical TRPML1 has the potential to treat neurodegenerative and lysosomal d...

Read More >>
Personalis unveils new service for cancer whole genome sequencing
  Author: Pankaj Singh

  The new launch of the services will help the company expand its oncology portfolio Personalis has been able to sequence more than 40...

Read More >>
Roches risdiplam meets primary endpoint results in phase 3 trial
  Author: Mateen Dalal

Spinal muscular atrophy (SMA) is a genetic neuromuscular condition, affecting approx. 1 in 6,000 babies born globally each year. Numerous healthcare companies throughout the world are putting their best foot fo...

Read More >>
Celltrion depicts CT-P13 SC efficacy for treating rheumatoid arthritis
  Author: Pankaj Singh

Celltrion Healthcare, a biopharmaceutical company, recently announced data from a study further investigating efficacy, safety, immunogenicity & pharmacokinetics of CT-P13 SC, over a period of 1-year treatment. The study focuses on the results...

Read More >>
AB Science receives Orphan Drug Designation from the FDA for AB8939
  Author: Mateen Dalal

AML (acute myeloid leukemia), a severe, life-threating disease that is one of the most common causes of cancer-related death. Common treatment options for this condition includes stem-cell transplants, chemotherapy and...

Read More >>
Tractus Vascular receives 510(k) clearance for its TractusTM CSC
  Author: Mateen Dalal

Vascular diseases are commonly termed as any abnormal condition that arises in the blood vessels (veins and arteries) which can lead to severe disability or death. Currently, there are several treatment alternativ...

Read More >>
TSI finalizes Phase 2 Study Protocol in Myocardial infarction
  Author: Mateen Dalal

Myocardial infarction (MI), commonly known as heart attack, occurs due to decrease in blood flow that damages heart muscles. Currently, MI treatment varies from making changes in lifestyle to medication and bypass...

Read More >>
FDA BRUDAC panel backs Agile Therapeutics’ Twirla contraceptive patch
  Author: Mateen Dalal

Agile Therapeutics, Inc., a renowned New Jersey based women’s healthcare and pharmaceutical company, has reportedly announced the positive outcome of a recent U.S. FDA Bone, Reproductive and Urologic Drugs Adviso...

Read More >>
UK MHRA assigns PIM status to ReveraGen’s Vamorolone as a DMD therapy
  Author: Mateen Dalal

Duchenne muscular dystrophy (DMD) approximately affects 1 in every 3,500 male births every year in the world. several biopharmaceutical and biotechnology firms across the globe are increasingly working towards the disc...

Read More >>
Imbrium doses first patient in Phase 2 IMB-115 trial to treat IAAC
  Author: Pankaj Singh

Insomnia associated with alcohol cessation (IAAC) is a major challenge faced by patients who are recovering from AUD (alcohol use disorder), struggling to achieve sustained abstinence from alcohol. Given the massive op...

Read More >>
Abeona Therapeutics unveils positive data from trial for RDEB therapy
  Author: Mateen Dalal

Various hereditary disorders and diseases are increasingly growing across the world which need to be treated effectively. Global pharmaceutical firms are increasingly working towards finding novel solutions to address ...

Read More >>
Sun Pharma unveils CEQUA in the US to treat dry eye disease patients
  Author: Mateen Dalal

Leading specialty generic pharmaceutical company Sun Pharmaceutical Industries Ltd has reportedly announced the launch of CEQUA (cyclosporine ophthalmic solution) 0.09% in the US by one of its subsidiaries. ...

Read More >>
Topcon partners with IBM for Merge Eye Station and Eye Care PACS users
  Author: Mateen Dalal

Ophthalmic device usage and production are projected to witness an exponential growth in the near future due to the growing prevalence of eye conditions. Various pharmaceutical firms across the world are increasingly t...

Read More >>
Gilead, Galapagos reveal FINCH 1 & FINCH 3 trial results of Filgotinib
  Author: Mateen Dalal

Autoimmune diseases are on a rise in today’s fast-paced world. Rheumatoid arthritis (RA) is one such clinical condition in which a patient’s immune system attacks its own tissue, including joints. In m...

Read More >>
Midatech initiates Phase 1 trial of a new hormonal cancer therapy
  Author: Mateen Dalal

Cancer treatment is one of the biggest challenges for the 21st century. There have been many advancements in the field of cancer treatment over the past few years. Clinical trial indeed plays a pivotal role in discover...

Read More >>
Yumanity starts Phase 1 trial of YTX-7739 to treat Parkinson’s disease
  Author: Pankaj Singh

Number of cases where people are affected with neurodegenerative diseases have been growing at a substantial pace. Alzheimer’s disease and Parkinson’s disease are the most common neurodegenerative diseases ...

Read More >>
Zydus reveals positive data from EVIDENCES IV phase 2 clinical trial
  Author: Mateen Dalal

Non-alcoholic Steatohepatitis (NASH) is a progressive disease which can ultimately lead to cirrhosis and liver failure. Liver transplantation is the only treatment for managing advanced cirrhosis with liver failure. Th...

Read More >>
AngioDynamics buys Eximo Medical and its 355nm Laser Atherectomy tech
  Author: Pankaj Singh

Owing to widescale tobacco use, the world is seeing an increased number of cancer and vascular diseases. India alone registers more than 10 million cases of peripheral artery disease on an annual basis. Technology and ...

Read More >>
Scholar Rock to showcase preclinical, phase 1 clinical data of SRK-015
  Author: Pankaj Singh

SMA is a rare genetic disease that typically affects young children. Currently, there is no cure for spinal muscular atrophy (SMA), however, various pharmaceutical firms across the world are working to discover a novel...

Read More >>
Noxxon reveals results from PHASE 1/2 trial of NOX-A12/KEYTRUDA®
  Author: Mateen Dalal

Colorectal cancer (CRC), also known as bowel or colon cancer, is a type of cancer that involves abnormal growth of cells that can invade or spread to other parts of the body. Growing prevalence of CRC has led...

Read More >>
CVS Pharmacy suspends sale of Zantac and CVS brand ranitidine products
  Author: Mateen Dalal

Lately, Carcinogens have found their way into the generic drug supply of the United States. In 2018, FDA found NDMA, a probable carcinogen for humans, in the widely-used valsartan tablets due to the impurities it had i...

Read More >>
Ipsen presents studies highlighting new approaches for severe cancers
  Author: Pankaj Singh

Today, people across the world are prone to numerous health disorders, and cancer is one of the major diseases which is growing at an alarming rate. Researchers around the world are putting their best foot forward to d...

Read More >>
Salarius obtains dose-escalation milestones for its Seclidemstat trial
  Author: Mateen Dalal

sarcoma is a type of bone cancer that can also appear in fat, muscle, deep skin tissues, blood vessels, tendons, ligaments and cartilage. Moreover, there are over 70 types of sarcoma, with each treatment vary...

Read More >>
Rigel’s ITP Drug Fostamatinib Enters Phase 3 Clinical Trial in Japan
  Author: Pankaj Singh

Chronic immune thrombocytopenia (ITP) is a disorder in which the body’s immune system destroys platelets which play a key role in blood clotting and healing. Currently, therapies such as steroids and splenectomy ...

Read More >>
Ipsen reveals promising results from a Phase IIIb/IV ENGAGE trial
  Author: Mateen Dalal

limb spasticity is a disorder that hampers the movement of the arms by stiffing the muscles. Spasticity is a result of the body’s damaged nervous system, which generally occurs due to disease, inju...

Read More >>
Oncology Venture’s DRP shows positive data to treat colorectal cancer
  Author: Pankaj Singh

Colorectal cancer, also known as colon cancer, rectal cancer or bowel cancer, affects a patient’s rectum and colon. Reportedly, it is the third most common type of cancer detected in both women and men ...

Read More >>
vTv Therapeutics unveils additional positive data from diabetic study
  Author: Pankaj Singh

TTP399 increased Time in Range, reduced hyperglycemia time, a bolus insulin dose that was lower and fewer hypoglycemic events.   TTP399...

Read More >>
Knopp posts data of KB-3061 working on KCNQ2 Epileptic Encephalopathy
  Author: Mateen Dalal

KCNQ2 epileptic encephalopathies is a serious type of neonatal epileptic condition which manifests in newborn children during the first week if their lives. This disease is being addressed by various pharmaceutical com...

Read More >>
Novo Nordisk and Medtronic team up to offer digital diabetes solutions
  Author: Mateen Dalal

With growing population of diabetic patients, diabetes management is becoming a daunting activity. Sugar level management and insulin injections tracking is a difficult work. Thus, leading pharmaceutical companies are ...

Read More >>
Akesis unveils its advanced Galaxy™ RTi and Gemini360 at ASTRO 2019
  Author: Mateen Dalal

The healthcare company will showcase its drugs in the ASTRO annual meeting 2019 that could help offer improved efficiency and confidence in treatment delivery. Ake...

Read More >>
Adverum reveals positive results from Phase 1 trial of ADVM-022
  Author: Mateen Dalal

The drug was well tolerated and was safe, and has shown the capacity to improve the treatment paradigm for patients with wet AMD. Adverum Biotechnologies, Inc., a c...

Read More >>
Apple initiates new medical studies focusing on various health issues
  Author: Mateen Dalal

The company plans to join various institutions in order to accomplish its new medical studies which focus on hearing, women’s health and mobility. Apple Inc.,...

Read More >>
Rocket Pharma unveils Phase 1/2 trial data for its Fanconi Anemia drug
  Author: Pankaj Singh

The manuscript includes data of the first four trial participants that were treated with RP-L102 under the Phase 1/2 FANCOLEN-I study.   ...

Read More >>
Inhibrx enrolls its first patient of Phase 1 trial of INBRX-101
  Author: Mateen Dalal

INBRX-101 is built to provide greater clinical activity to pdAAT by offering sustained improved concentration of plasma within a less frequent, regimen of monthly dosing.   &nb...

Read More >>
Genentech to present new data from neuroscience portfolio at ECTRIMS
  Author: Pankaj Singh

The data from the neuroscience portfolio would be showed at the 35th ECTRIMS between September 11 and 13 in Stockholm.   The...

Read More >>
Sony plans to release next-generation of NUCLeUS for hospitals
  Author: Mateen Dalal

The electronics giant is looking forward to putting forth the next-generation of its Smart Imaging Platform to offer hospitals a streamlined digital imaging work-flow. ...

Read More >>
Telix Pharmaceuticals announces launch of Renal cancer imaging study
  Author: Mateen Dalal

The pharmaceutical company declared the completion of CTN submission to Japanese PMDA for TLX250-CDx. It is permitted to conduct Phase trials for r...

Read More >>
Bio-Path begins patient dosing in amended Phase 2 Prexigebersen trial
  Author: Mateen Dalal

The trial focuses on the effects of Prexigebersen when combined with Decitabine and Venetoclax on AML patients. Bio-Path Holdings, Inc., a biotechnology company ren...

Read More >>
CStone announces 1st dosed patient in China for advanced GIST trial
  Author: Mateen Dalal

Leading biopharmaceutical expert CStone Pharmaceuticals has reportedly announced the first person in China to be dosed for the Phase I/II bridging trial of Avapritinib, discovered by Blueprint Medicines, a partner of C...

Read More >>
Sun Pharma signs pact with CMS for generic drug sales in China
  Author: Pankaj Singh

The pharmaceutical company has entered into an agreement with China Medical System Holdings to manufacture and manage 7 generic products in Mainland China.   ...

Read More >>
Trovagene to unveil key study data at APAC Prostate Cancer Conference
  Author: Mateen Dalal

Data from the Phase 2 Onvansertib clinical trial will be presented at the 20th Prostate Cancer Conference.   The trial asses...

Read More >>
Terns Pharma unveils positive interim output in Phase 1 TERN-201 trial
  Author: Pankaj Singh

Outputs from single ascending dose specify that TERN-201 is well tolerated and generally safe & can inhibit plasma SSAO activity.   ...

Read More >>
Novartis backs Zolgensma® to treat spinal muscular atrophy in children
  Author: Mateen Dalal

Zolgensma is specifically designed to be given to children below the age of two years with SMA.   The FDA acknowledged that there were ...

Read More >>
Alkahest reveals positive outcomes from Phase 2 study of GRF6019
  Author: Mateen Dalal

The study cites that dosing with GRF6019 were harmless and well-tolerated in patients with Alzheimer’s disease dementia (AD). Alkahest, Inc.,...

Read More >>
Precigen Inc. doses first patient in study of advanced cancer therapy
  Author: Mateen Dalal

PRGN-3005 UltraCAR-T is a type of multigenic CAR-T cell therapy which utilizes Precigens advanced non-viral gene delivery system Precigen Inc, a biopharmaceutical compa...

Read More >>
Risuteganib enhances visual acuity in patients with age-related dAMD
  Author: Pankaj Singh

· Patients enrolled to the clinical trial were given 1.0 mg of sham injection or risuteganib. · It would not be a helpful treatment for all pa...

Read More >>
I-Mab, TRACON Pharmaceuticals begins human trial of CD73 antibody TJD5
  Author: Pankaj Singh

The study will evaluate the tolerability and safety of TJD5 and determine recommended doses for future clinical studies. I-Mab Biopharma (I-Mab), a...

Read More >>
SELLAS doses first patient in study of GPS and KEYTRUDA® combination
  Author: Mateen Dalal

The trial involves patients diagnosed with acute myeloid leukemia and colorectal, ovarian, triple negative breast and small cell lung cancers. SELLAS Life Sciences...

Read More >>
Pfizer plans to merge with Mylan, will create an off-patent drug giant
  Author: Mateen Dalal

Mylan holds a market value worth $9.5 billion and has witnessed almost 50% fall in its shares over the last year Pfizer Inc., a multinational pharmaceutical company...

Read More >>
Merck unveils Phase 2b results of investigational HIV-1 therapy
  Author: Mateen Dalal

New findings come from evaluation of Doravirine combined with Islatravir versus DELSTRIGO.   The company plans to start Phase 3 trials ...

Read More >>
Curaleaf shares fall post FDA’s warning issued over false CBD claims
  Author: Pankaj Singh

The FDA warning had come after Curaleaf made unsubstantiated claims that their CBD (cannabidiol) based products can treat serious diseases.   ...

Read More >>
Ascentage to commence U.S. trials of HQP1351 in TKI resistant leukemia
  Author: Mateen Dalal

The Phase 1b clinical trial can accelerate HQP1351’s clinical development program globally Ascentage Pharma, a biotechnology company that is involved in the d...

Read More >>
Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial
  Author: Mateen Dalal

Ambrx will receive additional development payments with Bristol-Meyers’ initiation of the Phase 1 clinical trial for Relaxin Ambrx Inc., a biopharmaceutical c...

Read More >>
LifeSpan Bio acquires Everest Biotech to expand reagent portfolio
  Author: Mateen Dalal

The transaction will be LifeSpan BioSciences’ second investment this year following its Nordic-MUbio acquisition LifeSpan BioSciences (LSBio), a provider of l...

Read More >>
AbbVie buys Mavupharma to target STING pathway for cancer treatment
  Author: Mateen Dalal

AbbVie Inc., a US-based pharmaceutical company recently announced acquisition of Mavupharma, a Seattle-based biopharmaceutical company, which is focused on innovative strategies to target the STimulator of INterferon G...

Read More >>
Ligand Pharma announces positive results from trial of CE-Iohexol
  Author: Pankaj Singh

Ligand Pharmaceuticals, a US-based biopharmaceutical company recently announced positive top line results from clinical trial of its internal CE (Captisol-enabled) Iohexol program. The study attained primary endpo...

Read More >>
Cara begins Phase 2 trial of pruritus treatment in dermatitis patients
  Author: Mateen Dalal

The study is formulated to evaluate the safety and efficacy of Oral KORSUVA for moderate to severe pruritus Biopharmaceutical firm Cara Therapeutics Inc. has report...

Read More >>
Prestige BioPharma inks two new deals for its biosimilar trastuzumab
  Author: Mateen Dalal

The company would be able to supply and commercialize its biosimilar across Russia under the latest of the two deals.   The second deal...

Read More >>
DHOR closes acquisition of Parkview Community Hospital Medical Center
  Author: Pankaj Singh

DHOR had been administering Parkview under a management and operations transfer agreement as of February 2019 whilst waiting for HUD approval. Doctors Hospital of R...

Read More >>
Octapharma conveys update on development plan for SubQ-8 at ISTH 2019
  Author: Pankaj Singh

Octapharma has reportedly presented an update on the clinical development and pre-clinical data of SubQ-8 in a conference at the International Society on Thrombosis and Haemostasis Congress 2019. SubQ-8 integrates a hu...

Read More >>
Onco360® to be specialty pharmacy partner for Karyopharm’s XPOVIO™
  Author: Mateen Dalal

Onco360 will be able to support specialized needs of RRMM patients and their physicians across all the U.S. states The largest independent oncology pharmacy in U.S....

Read More >>
Iovance Bio updates cervical cancer program data post FDA meeting
  Author: Mateen Dalal

The innovaTIL-04 study is anticipated to register a total of 75 to 100 patients with the aim to support a BLA submission Reports confirm that Iovance Biotherapeutic...

Read More >>
Telix, Grupo RPH ink production & distribution agreement in Brazil
  Author: Mateen Dalal

The agreement gives Grupo RPH exclusive right to manufacture and distribute the TLX591-Cdx in the Latin American market Clinical-stage biopharmaceutical firm Telix ...

Read More >>
Strides Pharma inks deal with Arrow Pharma to sell Australian business
  Author: Mateen Dalal

It had earlier informed it will withdraw its investment in Arrow Pharmaceuticals for an agreed price of AUD 394 million Reports confirm that Strides Pharma Science,...

Read More >>
AVITA’s RECELL® System trial on DFU patients yields favorable results
  Author: Mateen Dalal

The 26-week observational study included 16 subjects at three different hospitals in the UK Global regenerative medicine company AVITA Medical has recently announce...

Read More >>
Ziopharm concludes enrollment in IL-12 & nivolumab combination trial
  Author: Mateen Dalal

Controlled IL-12 platform from Ziopharm is an investigational gene therapy designed to control and induce human interleukin 12 production Ziopharm Oncology Inc, a c...

Read More >>
NantKwest unveils first-in-human Phase 1 trial of its NK cell therapy
  Author: Mateen Dalal

PD-L1 t-haNK is a natural killing cell-based immuno-oncology therapy which includes Chimeric Antigen Receptor (CAR) based on PD-L1 NantKwest, leading company in cli...

Read More >>
Parexel unveils new integrated FPS model to boost clinical research
  Author: Mateen Dalal

Parexel stands as a pioneer in the delivery and development of a wide range of FSP, with full and flexible clinical development services Parexel, a leading global ...

Read More >>
UnitedHealth’s bid for DaVita Medical gets conditional FTC approval
  Author: Mateen Dalal

Within forty days of closure of the acquisition, UnitedHealth Group would divest DaVita Medical Group’s healthcare provider in Las Vegas UnitedHealth Group ha...

Read More >>
Rocket Pharma doses first patient in Phase 1 study of Danon treatment
  Author: Mateen Dalal

RP-A501 gene therapy can make a significant difference in patients who are suffering from Monogenic Heart Failure Syndrome Rocket Pharmaceuticals Inc, a multi-platf...

Read More >>
BioNTech & Genmab initiate trial of DuoBody-PD-L1x4-1BB to treat tumor
  Author: Pankaj Singh

BioNTech SE, the largest privately held biopharmaceutical company in Europe, recently announced initiation of first-in-human study of DuoBody-PD-L1x4-1BB for the treatment of solid tumors, cite sources. ...

Read More >>
Forty Seven publishes data on Phase 1b/2 clinical trial of 5F9
  Author: Mateen Dalal

A clinical-stage immune-oncology company, Forty Seven, Inc., that works to develop therapies targeting cancer immune evasion pathways, has revealed clinical data from Phase 1b/2. The company is evaluating a new drug co...

Read More >>
Progenics Pharma initiates clinical trial of 1095 radiotherapy
  Author: Pankaj Singh

Progenics Pharmaceuticals, Inc., a biopharmaceutical company, has recently announced that its first patient has been dosed for treatment of Metastatic Prostate cancer, in a phase 2 clinical study of 1095 radiotherapy. ...

Read More >>
FDA grants orphan drug tag to NuCana’s biliary tract cancer treatment
  Author: Mateen Dalal

NuCana is on its way to open a Global Phase III study of Acelarin in combination with cisplatin for patients who are suffering from the disease in 2019 NuCana plc r...

Read More >>
Aerpio initiates clinical trial of AKB-9778 for treatment of PAOG
  Author: Pankaj Singh

A US-based pharmaceutical company, Aerpio Pharmaceuticals, Inc., recently announced the initiation of Phase 1b clinical trial of AKB-9778 to develop treatment of PAOG (primary open angle glaucoma), report sources. ...

Read More >>
FDA gives nod to chemoimmunotherapy for patients suffering from DLBCL
  Author: Mateen Dalal

Polivy is an innovative antibody-drug conjugate developed with an intention of targeting specific cells Reports confirm that the US Food and Drug Administration has...

Read More >>
Dance Biopharm unveils positive Phase 2 trial data for inhaled insulin
  Author: Mateen Dalal

The new data further supports the potential of Dance 501 inhaled insulin in Type 2 diabetes patients Dance Biopharm Holdings, Inc has recently presented Phase 2 Sam...

Read More >>
Xynomic Inc. doses first patient in phase 1/2 Lymphoma trial
  Author: Pankaj Singh

A clinical stage oncology drug development company Xynomic Pharmaceuticals Holdings, Inc. has reportedly announced that it has dosed the first patient in a Phase 1/2 trial. Apparently, the trial combines abexinostat wi...

Read More >>
Takeda Pharma unveils new TOURMALINE-AL1 Phase-3 clinical trial update
  Author: Mateen Dalal

· The company announced that the clinical trial failed to fulfil the first of the two preestablished endpoints. · Citing the result of the ana...

Read More >>
American BriVision unveils positive ABV-1504 phase II results
  Author: Pankaj Singh

Clinical stage biopharmaceutical company American BriVision has reportedly released positive outcomes of its ABV-1504 Phase II clinical trial, under Taiwan FDA clinical protocol code of BLI-1005-002 and the U.S. Food a...

Read More >>
Mersana to share interim data of XMT-1536 from ongoing Phase 1 trial
  Author: Pankaj Singh

Clinical-stage biopharmaceutical company Mersana Therapeutics, Inc. has reportedly presented interim efficiency and safety data from its current Phase 1 dose-escalation study evaluating its first-in-class ADC candidate...

Read More >>
REGENXBIO announces completion of phase I/IIA RGX-314 clinical trial
  Author: Mateen Dalal

Every subject received one dose of RGX-314 managed by subretinal delivery. The leading clinical-stage biotechnology company REGENXBIO Inc. has recently announced that i...

Read More >>
Treos Bio announces results from trial of precision cancer vaccine
  Author: Mateen Dalal

Preliminary outcomes of the first part of the study have been made available and results of the second part are anticipated to be published in the third quarter of this year. ...

Read More >>
Novartis grants milestone payment to Cadent for Phase 2 MIJ821 trial
  Author: Mateen Dalal

MIJ821 is a potent and selective NMDA receptor modulator being developed for the treatment of treatment-resistant depression Cadent Therapeutics, a precision neuros...

Read More >>
89bio reports positive data from Phase 1 clinical trial of BIO89-100
  Author: Mateen Dalal

A clinical-stage biopharmaceutical company, 89bio LTD that focusses on NASH (nonalcoholic steatohepatitis), liver and other metabolic disorders, recently announced positive results from Phase 1 SAD (single ascending do...

Read More >>
UDG Healthcare acquires Incisive Health and Putnam Associates
  Author: Mateen Dalal

Both acquisitions are good cultural & strategic fit and meet the company’s financial hurdle rates while further expanding its current capabilities. ...

Read More >>
SpringWorks begins Phase 3 trial of desmoid tumor treatment in adults
  Author: Mateen Dalal

The company is looking forward to enrolling patients with desmoid tumors to confirm the clinical benefits of nirogacestat SpringWorks Therapeutics, a clinical-stage...

Read More >>
Cook Medical, Ambu A/S to jointly address endoscope-related infections
  Author: Pankaj Singh

The two firms will bring forth single-use endoscopes to patients undergoing ERCP procedures to reduce the risk associated with serious cross-contaminations. Medical...

Read More >>
Exelixis & Iconic Therapeutics ink exclusive license and option deal
  Author: Mateen Dalal

The exclusive license & option agreement has been signed for a new Antibody-Drug conjugate program.   The program, named ICON-2, sp...

Read More >>
Unichem Lab gets tentative nod from USFDA for hydrochloride medicines
  Author: Mateen Dalal

These tablets are indicated for nasal decongestant and antihistamine Unichem may produce and market the generic drug products after approval ...

Read More >>
Roche, Bio-Techne extend collaboration over mRNA ISH tissue analysis
  Author: Mateen Dalal

Roche’s new detection kits have more translucent dyes which are suited for mRNA ISH co-localization studies Swiss healthcare company Roche has recently announ...

Read More >>
Esperion confirms FDA acceptance of two NDAs for regulatory review
  Author: Mateen Dalal

The NDAs are for oral therapies developed as medication for patients with raised LDL-C who require additional LDL-C lowering Esperion has recently announced that th...

Read More >>
Innovation Pharma obtains FDA guidance for Brilacidin Phase 3 program
  Author: Mateen Dalal

Brilacidin oral rinse is supposedly being developed as part of FDA Fast Track designation for Oral Mucositis Reports confirm that Innovation Pharmaceuticals, a clin...

Read More >>
Cerevance successfully completes Phase 1 clinical trial of CVN424
  Author: Pankaj Singh

Clinical stage biopharmaceutical company Cerevance has reportedly completed its Phase 1 clinical trial of CVN424, the company’s first-in-class, oral drug in development for treating Parkinson’s disease. The...

Read More >>
EU CHMP recommends LYNPARZA as first-line treatment for ovarian cancer
  Author: Pankaj Singh

AstraZeneca & Merck’s LYNPARZA has reportedly received a positive opinion from the EMA’s (European Medicine Agency) CHMP (Committee for Medicinal Products for Human Use), for the first-line maintenance ...

Read More >>
Belite Bio’s IND for LBS-008 gets FDA approval for Phase 1 trial
  Author: Mateen Dalal

Drug development company, Belite Bio’s Investigational New Drug application for LBS-008 (BPN-14967), developed to treat AMD and Stargardt disease, has reportedly been approved by the U.S. Food and Drug Administra...

Read More >>
Innovent doses first patient in bispecific antibody clinical trial
  Author: Pankaj Singh

Innovent Biologics, Inc., a top-notch biopharmaceutical firm which produces and commercializes superior quality medications, has recently declared that the first patient has successfully been dosed in China in the Phas...

Read More >>
Cortexyme launches GAIN Trail to study COR388’s effects on Alzheimer s
  Author: Mateen Dalal

Cortexyme, Inc. has reportedly launched the GAIN Trial, a worldwide Phase 2/3 clinical trial of COR388, the company’s lead investigational drug, in patients suffering from mild to moderate Alzheimer’s disea...

Read More >>
Quanta’s SC+ HFT results published in Hemodialysis International
  Author: Mateen Dalal

The results from the SC+ HFT with patients as well as healthcare professionals prove that SC+ is easy to use even with a significant learning decay period and minimal training. ...

Read More >>
Otonomy begins OTO-313 Phase 1/2 clinical study for tinnitus patients
  Author: Mateen Dalal

Results from the trial are expected in the first half of 2020 and the information would be used to design and plan any further clinical development Biopharmaceutica...

Read More >>
Regeneron Alnylam collaborate on a $1bn eye & CNS R&D agreement
  Author: Pankaj Singh

Regeneron Pharmaceuticals Inc. and Alnylam Pharmaceuticals Inc. have reportedly entered into a definitive collaborative deal. Authentic sources claim that the deal has been inked in a major effort to discover, advance ...

Read More >>
I-Mab and Jiangsu Nhwa collaborate with Biodextris and Ann Romney CND
  Author: Mateen Dalal

The strategic partnership is aimed at jointly developing a new immuno-stimulatory therapy for certain neurologic disorders. I-Mab Biopharma, a Shanghai-based biotec...

Read More >>
Grow Biotech, IPS Specials join forces to offer medicinal cannabis
  Author: Mateen Dalal

A joint venture will combine IPS Specials’ abilities as a licensed pharma importer with medical cannabis expertise of Grow Biotech Reports confirm that IPS Sp...

Read More >>
Innate Pharma features innovative cancer immunotherapies at AACR 2019
  Author: Mateen Dalal

New data describes that a combination of Innate’s anti-CD39 monoclonal antibody and ATP-inducing oxaliplatin had enhanced the control of tumor growth Innate P...

Read More >>
FDA’s new mammography proposal to help enhance diagnosis accuracy
  Author: Mateen Dalal

The FDA (Food & Drug Administration) has reportedly proposed a new rule that would require mammography providers to inform female patients with dense breast tissue about the fact that the condition may impact the a...

Read More >>
Teladoc Health announces acquisition of France-based MedecinDirect
  Author: Pankaj Singh

The deal is expected to be closed in first half of this year   Financial terms of the deal were not disclosed yet ...

Read More >>
Aerie Pharmaceuticals commences Phase 2 clinical trial of AR-1105
  Author: Mateen Dalal

AR-1105 is an intravitreal, fully bio-erodible PRINT-manufactured implant that releases steroid dexamethasone. Aerie Pharmaceuticals, an ophthalmic pharmaceutical c...

Read More >>
Merck’s KEYTRUDA ® wins EC approval for treatment of NSCLC patients
  Author: Mateen Dalal

KEYTRUDA® combination significantly improved overall survival in adults with metastatic squamous NSCLC   Its safety in combination ...

Read More >>
FDA approves new generic valsartan to reduce the shortage of drug
  Author: Pankaj Singh

The regulator reviewed the manufacturing and testing practices of India-based Alkem Laboratories Limited and found no traces of impurity The United States Food and ...

Read More >>
Akili & Shionogi partnership to bring new digital therapeutics to Asia
  Author: Pankaj Singh

The new strategic partnership would see the two enterprises collaborate on the development & commercialization of digital therapeutics in crucial Asian markets.   ...

Read More >>
Almac Group unveils Almac One solution for clinical trial supply chain
  Author: Mateen Dalal

Almac One™ would help sponsors to face the challenges existing in the drug development market It provide a single set of process to sponsors and enabl...

Read More >>
GE Healthcare and Adventist sign performance enhancement collaboration
  Author: Mateen Dalal

The five-year collaboration is expected to bring about financial improvement amounting to almost $100 million. GE Healthcare and Adventist Health, two of the most r...

Read More >>
BioXcel adds Pfizer, Merck to pancreatic cancer therapy collaboration
  Author: Mateen Dalal

BioXcel Therapeutics, Inc. has made an announcement confirming the addition of Germany-based Merck KGaA as well as Pfizer Inc. to its clinical collaboration with Nektar Therapeutics for evaluating an innovative triple ...

Read More >>
Novartis data confirms rapid response of Cosentyx® in China study
  Author: Mateen Dalal

The study proves to offer clear or almost clear skin in 8/10 patients within 16 weeks of Cosentyx® 300mg treatment. Swiss pharmaceutical major, Novartis AG (NVS...

Read More >>
Verrica announces positive results for molluscum contagiosum treatment
  Author: Mateen Dalal

The treatment would help to address unmet medical needs against serious skin lesions Reports suggest that the lead candidate of Verrica Pharmaceuticals, a drug-devi...

Read More >>
Hua Medicine confirms patient enrollment for study of diabetes drug
  Author: Mateen Dalal

Shanghai-based drug development firm Hua Medicine, which focuses on developing global first-in-class oral drug for treating Type 2 diabetes, has recently announced that it has completed patient enrollment for a Phase I...

Read More >>
Atara Biotherapeutics to present clinical results of Car T platform
  Author: Pankaj Singh

The firm is looking forward to its MSK collaborators’ clinical outcomes of a mesothelin-targeted autologous CAR T for patients suffering from advanced malignant pleural ailment &nbs...

Read More >>
GNA & Boehringer collaborate on ASF diagnostic test development
  Author: Pankaj Singh

Both the companies will come up with holistic solutions for farmers, veterinarians, and the food producing industry. The partnership aims to develop a ...

Read More >>
Sarepta to buy Myonexus to expand muscular dystrophy therapy portfolio
  Author: Mateen Dalal

Sarepta Therapeutics has recently confirmed that it is planning to acquire Myonexus Therapeutics in a $165 million deal, by exercising a purchase option that was part of a gene therapy partnership commenced by the firm...

Read More >>
Scholar Rock’s Phase 1 study of SRK-015 delivers positive interim data
  Author: Mateen Dalal

Scholar Rock Holding Corporation, the clinical-stage biopharma company focusing on treating serious diseases which are affected by protein growth factors, has recently confirmed positive interim results for its Phase 1...

Read More >>
Ocutrx develops advanced Oculenz AR glasses with eye-tracking ability
  Author: Mateen Dalal

California-based augmented reality (AR) glasses manufacturer, Ocutrx Vision Technologies, LLC, has recently unveiled its new, cutting-edge design for Oculenz™ AR Wear glasses, which is the company’s flagshi...

Read More >>
Morphic to collaborate with Janssen to develop integrin therapeutics
  Author: Mateen Dalal

Morphic has attained leadership position in the development of oral integrin inhibitors with the help of the ground-breaking structural research Morphic Therapeutic...

Read More >>
AzurRx doses first patients in Phase II OPTION study for EPI therapy
  Author: Mateen Dalal

AzurRx BioPharma, Inc. has recently informed that the company has dosed the first patients in its Phase II OPTION clinical study aimed at investigating MS1819-SD in cystic fibrosis (CF) patients who experience exocrine...

Read More >>
Indivior introduces generic version of its Suboxone opioid drug
  Author: Pankaj Singh

The company said its launch of an authorize generic version of the drug would prompt other firms to introduce their own cheaper versions The announ...

Read More >>
Philippines FDA bans Sanofis dengue vaccine due to compliance issue
  Author: Mateen Dalal

Reports confirm that the Philippines has revoked the product license for Dengvaxia, the dengue vaccine from Sanofi, after the France-based pharmaceutical company failed to comply with directives of regulators. Apparently...

Read More >>
CASI Pharma gets NMPA’s nod to conduct confirmatory trial of ZEVALIN®
  Author: Mateen Dalal

The firm previously secured greater China rights to ZEVALIN® from Spectrum and aims to launch ZEVALIN® in the country. CASI Pharmaceutical...

Read More >>
Inventiva declares results of Phase IIb clinical trial of lanifibranor
  Author: Mateen Dalal

The FASST clinical trial failed to meet its primary endpoint of a mean absolute change from baseline to week 48 The French clinical-stage biopharmaceutical firm Inv...

Read More >>
Merck presents data from new Phase 3 trials to treat mCRPC patients
  Author: Mateen Dalal

Pharmaceutical major Merck & Co Inc., has apparently announced the launch of three late-stage studies for KEYTRUDA – its cancer immunotherapy. Trusted reports cite that these studies are being introduced as a...

Read More >>
Life science firm Jubilant & Sanofi collaborate on CNS therapeutics
  Author: Mateen Dalal

Jubilant will deliver Sanofi drug discovery services with its integrated drug discovery platform. The Bengaluru-based arm of the reputed Jubilant Life Sciences, Jub...

Read More >>